BACKGROUND:Up to now, surgical excision of apocrine glands still has been a method that yields high treatment results and low rate of odour recurrent for patients, but many people worry about some serious complications that have been observed postoperatively, such as hematoma and skin necrosis. These prolong wound healing, leading to unsightly scars in the axillary fossae.AIM:We conducted this research to investigate the effects and complications of our surgical technique for axillary bromhidrosis.METHODS:Forty-three patients with axillary bromhidrosis were treated. An elliptical incision was made at a central portion of the area marked, with both tips of the ellipse along the axillary crease. The elliptical skin with the subcutaneous tissue was removed en lock. The adjacent skin was undermined to the periphery of the hair-bearing area with straight scissors. The undermined subcutaneous tissue was removed with curved scissors, and the skin was defatted to become a full-thickness skin flap. Any suspected hemorrhagic spots were immediately coagulated electrosurgically. Appropriate drains were placed, and the treated area was covered with thick gauze to each axilla. Arm movement was strictly controlled in the first 3 days post-operatively.RESULTS:Thirty-one patients have been followed up and evaluated for 6 months. 56 out of 62 axillae (90.3%) showed good to excellent results for malodor elimination. All patients reported a reduction in axillary sweating. There were two axillae of skin necrosis and three axillae of hematoma, with one patient receiving an anticoagulant from a cardiologist after the first day of surgery, to treat heart valve disease. The Dermatology Life Quality Index (DLQI) score decreased significantly, and the quality of life improved after the operation.CONCLUSION:Our technique is a simple surgical procedure and easy to perform helping to achieve results for high malodor elimination, with almost no serious complications. Patient’s life quality improved significantly after the operation.
BACKGROUND:Nevus Sebaceous (NS) is hamartoma predominantly composed of sebaceous glands and is classified as a type of epidermal nevus. In most case, clinical manifestation of NS is typical, so histopathology examination is important only in atypical lesions for its risk of malignancy. Clinical symptoms are plaques or papules (100%), appearing in the head area (100%) with smooth surface (65.8%), usually with hair loss (60.7%). The histopathology is mostly characterized by the image of sebaceous gland hyperplasia (100%), no hair follicles (60.7%) or immature follicles (14.3%).AIM:The aim of our study is describing clinical and histopathological manifestation, make diagnosis and evaluate the best therapy.METHODS:Our study recruited 38 patients with NS, 3 patients (7.9%) with atypical aspects. All patients were treated by surgical excision.RESULTS:Complications as hair loss and infections were reported in 36.8% patients. No patients had recurrence after one year of treatment.CONCLUSION:Based upon our experience, surgery is cheap, simple, associated with high aesthetics effectiveness and low recurrence rate, proposing as the first choice for treatment of NS.
OBJECTIVES:This study aims to evaluate the effectiveness of Alex Trivantage laser wavelength 755 nm (ATL) in the treatment of freckles at Hanoi Hospital of Dermatology and Venereology, Vietnam.PATIENTS AND METHODS:A group of 30 patients with freckles were treated by ATL (Alex Trivantage-Candela Co America) with spots size 3 mm, wavelength 755 mm, and energy 5-6 j/cm2. All the patients were treated 2 times with 4-weeks interval. The results were evaluated at 4, 8, and 12 weeks after treatment. The colour of the lesions was evaluated by using Von-Luchan’s chromatic scale and Visia® complex analysis system. Brown spot index (BSI) was calculated by the VISA complexion analysis system devices. The data was analysed by SPSS 16.0.RESULTS:After 2 times of treatment, the lesion colour of all of the patients had been improved. The good and very good levels of improvement were noted in 63.3% of patients; there was 26.7% of them had partial improvement. Brown spots index was significantly improved (39.13 ± 20.66 before and 54.23 ± 16.78 after treatment; p < 0.001). Hyperpigmentation was noted in 6.7% of patients.CONCLUSION:freckles have been improved by treatment with Alex trivantage laser wavelength 755 nm with safety.
Objectives: To investigate the current situation of skin cancer in the National Hospital of Dermatology and Venereology (NHDV) with an emphasis on epidemiology and time trends over 5-year period from 2017 to 2021.Subjects and methods: We analyzed medical data of all patients with definitive diagnosis of skin cancer who were hospitalized at the NHDV between January 2017 and December 2021. Results: A total of 866 patients were identified. There were 579 (66.86%) cases of basal cell carcinoma (BCC), 238 (27.48%) cases of squamous cell carcinoma (SCC), 22 (2.54%) cases of melanoma, and other types of skin cancer occurred in 3.12% (27 cases) of patients. The age group over 60 years old accounted for 60.28% of patients. The mean age of patients with BCC gradually decreased from 65.01 in 2017 to 61.64 in 2021 and the proportion of patients under 60 years old increased statistically significantly over the years (p < 0.01). The male/female ratio was 0.97 (p = 0.715) and 71.02% of the patients lived in rural areas.Conclusion: BCC is the most common type of skin cancer. About 60% of skin cancer patients were diagnosed at age ≥ 60 but tend to be younger. Men and women have similar incidence of skin cancer and the majority of patients live in rural areas.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.